日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escape

预先优化临床抗体,使其能够广泛中和SARS-CoV-2变异株并增强其抵抗病毒逃逸的能力

Zhu, Fangqiang; Rajan, Saravanan; Hayes, Conor F; Kwong, Ka Yin; Goncalves, Andre R; Zemla, Adam T; Lau, Edmond Y; Zhang, Yi; Cai, Yingyun; Goforth, John W; Landajuela, Mikel; Gilchuk, Pavlo; Kierny, Michael; Dippel, Andrew; Amofah, Bismark; Kaplan, Gilad; Cadevilla Peano, Vanessa; Morehouse, Christopher; Sparklin, Ben; Gopalakrishnan, Vancheswaran; Tuffy, Kevin M; Nguyen, Amy; Beloor, Jagadish; Kijak, Gustavo; Liu, Chang; Dijokaite-Guraliuc, Aiste; Mongkolsapaya, Juthathip; Screaton, Gavin R; Petersen, Brenden K; Desautels, Thomas A; Bennett, Drew; Conti, Simone; Segelke, Brent W; Arrildt, Kathryn T; Kaul, Samantha; Grzesiak, Emilia A; da Silva, Felipe Leno; Bates, Thomas W; Earnhart, Christopher G; Hopkins, Svetlana; Sundaram, Shivshankar; Esser, Mark T; Francica, Joseph R; Faissol, Daniel M

Epidemiology, Real-World Treatment Patterns, and Patient Outcomes of Primary Advanced or Recurrent Endometrial Cancer in Germany between 2015 and 2021

2015年至2021年德国原发性晚期或复发性子宫内膜癌的流行病学、真实世界治疗模式和患者预后

Mevius, Antje; Lutter, Johanna; Karl, Florian M; Tuffy, Liam; Schochter, Fabienne; Fuchs, Andreas; Wilke, Thomas

Region-Specific Phosphorylation Determines Neuroligin-3 Localization to Excitatory Versus Inhibitory Synapses.

区域特异性磷酸化决定了神经连接蛋白-3在兴奋性突触和抑制性突触中的定位

Altas Bekir, Tuffy Liam P, Patrizi Annarita, Dimova Kalina, Soykan Tolga, Brandenburg Cheryl, Romanowski Andrea J, Whitten Julia R, Robertson Colin D, Khim Saovleak N, Crutcher Garrett W, Ambrozkiewicz Mateusz C, Yagensky Oleksandr, Krueger-Burg Dilja, Hammer Matthieu, Hsiao He-Hsuan, Laskowski Pawel R, Dyck Lydia, Puche Adam C, Sassoè-Pognetto Marco, Chua John J E, Urlaub Henning, Jahn Olaf, Brose Nils, Poulopoulos Alexandros

Serum AZD7442 (tixagevimab-cilgavimab) concentrations and in vitroIC(50) values predict SARS-CoV-2 neutralising antibody titres

血清AZD7442(tixagevimab-cilgavimab)浓度和体外IC(50)值可预测SARS-CoV-2中和抗体滴度

Clegg, Lindsay E; Stepanov, Oleg; Matthews, Sam; White, Tom; Seegobin, Seth; Thomas, Steven; Tuffy, Kevin M; Någård, Mats; Esser, Mark T; Streicher, Katie; Cohen, Taylor S; Aksyuk, Anastasia A

Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protection

nirsevimab 的 Fc 介导功能可补充直接中和呼吸道合胞病毒,但并非实现最佳预防性保护所必需的

Tyler Brady, Corinne Cayatte, Tiffany L Roe, Scott D Speer, Hong Ji, LeeAnn Machiesky, Tianhui Zhang, Deidre Wilkins, Kevin M Tuffy, Elizabeth J Kelly

Breakthrough SARS-CoV-2 Infections in the PROVENT Prevention Trial Were Not Associated With AZD7442 (Tixagevimab/Cilgavimab) Resistant Variants

PROVENT预防试验中突破性SARS-CoV-2感染与AZD7442(Tixagevimab/Cilgavimab)耐药变异株无关

Tuffy, Kevin M; Ahani, Bahar; Aksyuk, Anastasia A; Avila, Miles; Brady, Tyler; Kijak, Gustavo H; Koh, Gavin; Levin, Myron J; Roe, Tiffany L; Schuko, Nicolette; Thissen, Jesse; Ustianowski, Andrew; Zhang, Tianhui; Kelly, Elizabeth J; Streicher, Katie

S-SCAM is essential for synapse formation

S-SCAM 对突触形成至关重要

Nina Wittenmayer, Andonia Petkova-Tuffy, Maximilian Borgmeyer, Chungku Lee, Jürgen Becker, Andreas Böning, Sebastian Kügler, JeongSeop Rhee, Julio S Viotti #, Thomas Dresbach #

Molecular Characterization of AZD7442 (Tixagevimab-Cilgavimab) Neutralization of SARS-CoV-2 Omicron Subvariants

AZD7442(Tixagevimab-Cilgavimab)对SARS-CoV-2 Omicron亚型中和作用的分子特征

Roe, Tiffany L; Brady, Tyler; Schuko, Nicolette; Nguyen, Amy; Beloor, Jagadish; Guest, Johnathan D; Aksyuk, Anastasia A; Tuffy, Kevin M; Zhang, Tianhui; Streicher, Katie; Kelly, Elizabeth J; Kijak, Gustavo H

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans

SARS-CoV-2单克隆抗体组合AZD7442在非人灵长类动物中具有保护作用,并且在人体内具有较长的半衰期。

Loo, Yueh-Ming; McTamney, Patrick M; Arends, Rosalinda H; Abram, Michael E; Aksyuk, Anastasia A; Diallo, Seme; Flores, Daniel J; Kelly, Elizabeth J; Ren, Kuishu; Roque, Richard; Rosenthal, Kim; Streicher, Katie; Tuffy, Kevin M; Bond, Nicholas J; Cornwell, Owen; Bouquet, Jerome; Cheng, Lily I; Dunyak, James; Huang, Yue; Rosenbaum, Anton I; Pilla Reddy, Venkatesh; Andersen, Hanne; Carnahan, Robert H; Crowe, James E Jr; Kuehne, Ana I; Herbert, Andrew S; Dye, John M; Bright, Helen; Kallewaard, Nicole L; Pangalos, Menelas N; Esser, Mark T

Validation and performance of a multiplex serology assay to quantify antibody responses following SARS-CoV-2 infection or vaccination

验证并执行多重血清学检测以量化 SARS-CoV-2 感染或接种疫苗后的抗体反应

Deidre Wilkins, Anastasia A Aksyuk, Alexey Ruzin, Kevin M Tuffy, Tina Green, Rebecca Greway, Brittany Fikes, Cyrille J Bonhomme, Mark T Esser, Elizabeth J Kelly